EUVIMEDEUVIMED entdecken
Crossref

Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment

Christopher Dardis, Kelly Milton, Neel Patel

Oncomedicine · 2017

DOI: 10.7150/oncm.17909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Christopher Dardis und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dardis, C., Milton, K., & Patel, N. (2017). Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment. Oncomedicine. https://doi.org/10.7150/oncm.17909

Vancouver

Dardis C, Milton K, Patel N. Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment. Oncomedicine. 2017. doi:10.7150/oncm.17909

BibTeX
@article{Dardis2017,
  author = {Dardis, Christopher and Milton, Kelly and Patel, Neel},
  title = {Thrombopoietin Receptor Agonists are Effective in Treating Chemotherapy-induced Thrombocytopenia in Patients with Gliomas Undergoing Myelotoxic Treatment},
  journal = {Oncomedicine},
  year = {2017},
  doi = {10.7150/oncm.17909}
}
Kostenlos starten →